Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes

Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes

Imbalance between oxidative stress burden and antioxidant capacity is implicated in the course of atherosclerosis among type 2 diabetic patients. We addressed the effects of insulin, glucagon-like peptide-1 receptor agonists (GLP1-RA), sodium-glucose cotransporter-2 inhibitors (SGLT-2i), and their c...

Full description

Bibliographic Details
Main Authors: Vaia Lambadiari, John Thymis, Dimitris Kouretas, Zoi Skaperda, Fotios Tekos, Foteini Kousathana, Aikaterini Kountouri, Konstantinos Balampanis, John Parissis, Ioanna Andreadou, Maria Tsoumani, Christina Chania, Konstantinos Katogiannis, George Dimitriadis, Aristotelis Bamias, Ignatios Ikonomidis
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Antioxidants
Subjects:
glucagon-like peptide-1 receptor agonists
sodium-glucose cotransporter-2 inhibitors
Malondialdehyde
Thiobarbituric Acid Reactive Substances
2,2¢-azino-bis-(3-ethylbenzthiazoline-6-sulphonic acid) radical
Online Access:https://www.mdpi.com/2076-3921/10/9/1379

Similar Items

Similar Items